PRL and thanatophoric dysplasia: The proportion of PSPA-nt patients having specific signs of TD decreased from 28% (at baseline) to 0% at the time of prolactin normalization (P = .0096), whereas their rate was unchanged in PA-nt patients (3.3 to 1.6%, Fig. 3A).